Biotech

All Articles

Enanta's RSV antiviral crushes viral tons in obstacle study

.Enanta Pharmaceuticals has actually connected its breathing syncytial virus (RSV) antiviral to sign...

Biogen cans SAGE-324 collaboration after crucial tremor stop working

.Biogen has conducted the final ceremonies to its partnership with Sage Therapies on SAGE-324, ditch...

AbbVie Parkinson's medicine from $8.7 B Cerevel buyout ratings

.On the same day that some Parkinson's ailment drugs are being actually cast doubt on, AbbVie has ac...

Arch finalizes $3B-plus fund to promote biopharma startups

.On the heels of a $3 billion fund coming from Bain Funds Life Sciences, Arch Project Allies is veri...

Orion to use Aitia's 'electronic doubles' to discover new cancer cells medicines

.Finnish biotech Orion has actually spied potential in Aitia's "electronic identical twin" tech to d...

Windtree's shock med increases blood pressure in newest period 2 gain

.While Windtree Rehabs has actually strained to expand the economic origins needed to make it throug...

2 cancer cells biotechs merge, producing global impact

.OncoC4 is taking AcroImmune-- as well as its own in-house medical manufacturing capabilities-- unde...

Amgen files 1st phase 3 win for $400M dermatitis medicine

.Amgen has actually shared (PDF) the first period 3 records on its $400 thousand dermatitis drug, li...

Biogen, UCB report period 3 lupus succeed after failing earlier test

.Biogen as well as UCB's depend improving in to period 3 astride a failed study hopes to have repaid...

Aptadir wishes brand-new RNA preventions may turn around difficult cancers

.Italian biotech Aptadir Therapies has launched along with the assurance that its own pipeline of pr...